{"cik":2130606,"taxonomy":"us-gaap","tag":"NetIncomeLoss","label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","entityName":"OBSIDIAN THERAPEUTICS, INC.","units":{"USD":[{"start":"2024-01-01","end":"2024-12-31","val":-83109000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2024"},{"start":"2025-01-01","end":"2025-03-31","val":-24986000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2025Q1"},{"start":"2025-01-01","end":"2025-06-30","val":-51882000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28"},{"start":"2025-04-01","end":"2025-06-30","val":-26896000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2025Q2"},{"start":"2025-01-01","end":"2025-12-31","val":-100607000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":-19633000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2026Q1"},{"start":"2026-01-01","end":"2026-06-30","val":-45497000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28"},{"start":"2026-04-01","end":"2026-06-30","val":-25864000,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2026Q2"},{"start":"2026-04-11","end":"2026-06-30","val":0,"accn":"0001193125-26-352381","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-14"}]}}